Samumed raises $438 million to fund regenerative medicine development
The company plans to use the funding to advance clinical candidates and expand its portfolio, which touches a wide range of diseases.
The company plans to use the funding to advance clinical candidates and expand its portfolio, which touches a wide range of diseases.